HealthEquity Inc. logo

HealthEquity Inc. (HQY)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
92. 03
-0.48
-0.5189%
$
7.65B Market Cap
214.37 P/E Ratio
- Div Yield
550,700 Volume
2.14 Eps
$ 92.51
Previous Close
Add Transaction
Day Range
91.62 93.83
Year Range
72.76 107.62
Want to track HQY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Is HealthEquity (HQY) Down 4.3% Since Last Earnings Report?

Why Is HealthEquity (HQY) Down 4.3% Since Last Earnings Report?

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock?

Zacks | 2 years ago
Is HealthEquity Stock a Buy Now Amid Strength in HSAs?

Is HealthEquity Stock a Buy Now Amid Strength in HSAs?

HQY's strong quarterly results and solid top-line growth raise optimism about the stock.

Zacks | 2 years ago
Looking for a Growth Stock? 3 Reasons Why HealthEquity (HQY) is a Solid Choice

Looking for a Growth Stock? 3 Reasons Why HealthEquity (HQY) is a Solid Choice

HealthEquity (HQY) could produce exceptional returns because of its solid growth attributes.

Zacks | 2 years ago
Wall Street Analysts Think HealthEquity (HQY) Could Surge 32.88%: Read This Before Placing a Bet

Wall Street Analysts Think HealthEquity (HQY) Could Surge 32.88%: Read This Before Placing a Bet

The mean of analysts' price targets for HealthEquity (HQY) points to a 32.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks | 2 years ago
Here's Why HealthEquity (HQY) is a Strong Growth Stock

Here's Why HealthEquity (HQY) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 years ago
Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term

Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 2 years ago
HQY vs. MEDP: Which Stock Is the Better Value Option?

HQY vs. MEDP: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical Services sector have probably already heard of HealthEquity (HQY) and Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 2 years ago
3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)

3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)

HealthEquity (HQY) could produce exceptional returns because of its solid growth attributes.

Zacks | 2 years ago
Wall Street Analysts Believe HealthEquity (HQY) Could Rally 36.59%: Here's is How to Trade

Wall Street Analysts Believe HealthEquity (HQY) Could Rally 36.59%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 36.6% in HealthEquity (HQY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks | 2 years ago
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term

Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 2 years ago
HealthEquity Stock May Gain From Its Latest Partnership With Paytient

HealthEquity Stock May Gain From Its Latest Partnership With Paytient

HQY collaborates with Paytient to enhance employees' access to healthcare through Health Payment Accounts.

Zacks | 2 years ago
HealthEquity Stock Rises on Q2 Earnings and Revenue Beat

HealthEquity Stock Rises on Q2 Earnings and Revenue Beat

HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.

Zacks | 2 years ago
Loading...
Load More